International Stem Cell Corporation Launches Stroke Program With Tulane University

Together with , ISCO will study the impact of human parthenogenetic neural stem cells transplantation in a pre-clinical rodent model of ischemic stroke as a first step toward the clinical development of a potential stroke treatment.

http://ift.tt/1p7DiU2